UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia

Diabetes, obesity & metabolism, 2012-01, Vol.14 (1), p.5-14

2012

Volltextzugriff (PDF)

Nonlinear Control for Blood Glucose Regulation of Diabetic Patients: An LMI Approach

2022

Volltextzugriff (PDF)

What does sodium‐glucose co‐transporter 1 inhibition add: Prospects for dual inhibition

Diabetes, obesity & metabolism, 2019-04, Vol.21 (S2), p.43-52

2019

Volltextzugriff (PDF)

Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?

Diabetes, obesity & metabolism, 2021-09, Vol.23 (9), p.2009-2019

2021

Volltextzugriff (PDF)

Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity

Diabetes, obesity & metabolism, 2017-08, Vol.19 (8), p.1135-1146

2017

Volltextzugriff (PDF)

Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin

Diabetes, obesity & metabolism, 2022-04, Vol.24 (4), p.599-608

2022

Volltextzugriff (PDF)

Uric acid and the cardio‐renal effects of SGLT2 inhibitors

Diabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1291-1298

Bailey, Clifford J.

2019

Volltextzugriff (PDF)

The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes

Diabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1311-1321

2019

Volltextzugriff (PDF)

Changes in the use of glucose‐lowering drugs: A Danish nationwide study

Diabetes, obesity & metabolism, 2023-04, Vol.25 (4), p.1002-1010

2023

Volltextzugriff (PDF)

One‐hour post‐load plasma glucose predicts progression to prediabetes in a multi‐ethnic cohort of obese youths

Diabetes, obesity & metabolism, 2019-05, Vol.21 (5), p.1191-1198

2019

Volltextzugriff (PDF)

In vivo glucose sensing

1st ed., 2009

Volltextzugriff (PDF)

Efficacy of 1‐hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes‐related complications: A post hoc analysis of the 30‐year follow‐up of the Da Qing IGT and Diabetes Study

Diabetes, obesity & metabolism, 2024-06, Vol.26 (6), p.2329-2338

2024

Volltextzugriff (PDF)

Sodium‐glucose co‐transporter‐2 inhibitors as add‐on therapy to insulin for type 1 diabetes mellitus: Systematic review and meta‐analysis of randomized controlled trials

Diabetes, obesity & metabolism, 2018-07, Vol.20 (7), p.1755-1761

2018

Volltextzugriff (PDF)

The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals

Diabetes, obesity & metabolism, 2024-03, Vol.26 (3), p.1033-1039

2024

Volltextzugriff (PDF)

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

Diabetes, obesity & metabolism, 2013-05, Vol.15 (5), p.463-473

2013

Volltextzugriff (PDF)

Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial

Diabetes, obesity & metabolism, 2023-01, Vol.25 (1), p.110-120

2023

Volltextzugriff (PDF)

Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial

Diabetes, obesity & metabolism, 2019-11, Vol.21 (11), p.2505-2512

2019

Volltextzugriff (PDF)

Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients

Diabetes, obesity & metabolism, 2017-06, Vol.19 (6), p.809-813

2017

Volltextzugriff (PDF)

Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon‐like peptide‐1, and gastric emptying after oral glucose, in type 2 diabetes

Diabetes, obesity & metabolism, 2019-03, Vol.21 (3), p.640-647

2019

Volltextzugriff (PDF)

Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study

Diabetes, obesity & metabolism, 2015-08, Vol.17 (8), p.800-804

2015

Volltextzugriff (PDF)

Sodium‐glucose co‐transporter‐2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open‐label, 3‐arm parallel comparative, exploratory study

Diabetes, obesity & metabolism, 2017-05, Vol.19 (5), p.739-743

2017

Volltextzugriff (PDF)

Sodium‐glucose co‐transporter‐2 inhibitors and diabetic ketoacidosis: An updated review of the literature

Diabetes, obesity & metabolism, 2018-01, Vol.20 (1), p.25-33

2018

Volltextzugriff (PDF)

Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals

Diabetes, obesity & metabolism, 2018-01, Vol.20 (1), p.94-102

2018

Volltextzugriff (PDF)

Decreased complexity of glucose time series index associated with adverse pregnancy outcomes in gestational diabetes mellitus

Diabetes, obesity & metabolism, 2024-09, Vol.26 (9), p.3587-3596

2024

Volltextzugriff (PDF)

Beta‐cell sensitivity to glucose is impaired after gastric bypass surgery

Diabetes, obesity & metabolism, 2018-04, Vol.20 (4), p.872-878

2018

Volltextzugriff (PDF)

1 – 25 von 95.374

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

KollektionOxford Journals Current Collection

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(31.732)

Publikationsform

Artikel
(67.601)
Newsletter-Artikel
(6.834)
Zeitungsartikel
(5.997)
Dissertationen
(5.772)
magazinearticle
(3.510)
Buchkapitel
(2.703)
Tagungsberichte
(2.343)
Bücher
(293)
Referenzeintrag
(158)
Berichte
(124)
Normen
(17)
Reviews
(16)
Webseiten
(3)
Texte
(2)
Datensätze
(1)

10 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(71.172)
Deutsch
(6.459)
Japanisch
(3.777)
Französisch
(3.725)
Chinesisch
(2.210)
Italienisch
(1.914)
Portugiesisch
(1.822)
Russisch
(1.698)
Spanisch
(1.036)
Polnisch
(401)
Niederländisch
(262)
Dänisch
(256)
Ukrainisch
(203)
Tschechisch
(185)
Rumänisch
(184)
Türkisch
(143)
Serbian
(137)
Bulgarisch
(117)
Finnisch
(97)
Schwedisch
(79)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Glucose
(35.075)
Humans
(33.601)
Science & Technology
(25.802)
Life Sciences & Biomedicine
(23.369)
Male
(19.127)
Diabetes
(18.306)
Animals
(17.776)
Female
(17.031)
Adult
(10.831)
Blood Glucose
(10.244)
Glucose - Metabolism
(10.173)
Blood Glucose - Analysis
(9.791)
Middle Aged
(9.665)
Insulin
(9.568)
Blood Glucose - Metabolism
(9.475)
Rats
(8.162)
Aged
(5.930)
Endocrinology & Metabolism
(5.816)
Glucose Tolerance Test
(5.743)
Diabetes Mellitus
(5.562)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(52.579)
EZB Electronic Journals Library
(17.840)
Nexis Uni
(16.920)
Ingenta
(9.569)
Journals@Ovid Full Text
(8.402)
ProQuest Dissertations & Theses A&I
(5.772)
SpringerLink
(5.542)
Publisher or Other Site
(5.522)
Wiley-Blackwell Journals
(4.872)
IngentaConnect Journals
(4.800)
Wiley Online Library Full Collection 2018
(3.797)
Ebook Central Perpetual and DDA
(2.705)
eBooks on EBSCOhost
(2.583)
IEEE/IET Electronic Library (IEL)
(2.369)
Access via Business Source (EBSCOhost)
(2.233)
Access via ScienceDirect (Elsevier)
(1.112)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.078)
Taylor & Francis Online
(1.069)
Taylor & Francis Journals
(979)
Wiley Online Library All Obooks
(970)
Oxford Journals
(0)

16 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetes, Obesity & Metabolism
(2.655)
Pr Newswire
(2.338)
Reactions Weekly
(1.504)
M2 Presswire
(1.168)
Business Wire
(1.142)
Diabetes, Obesity & Metabolism/diabetes, Obesity And Metabolism
(991)
Nihon Rinshō
(908)
International Journal Of Endocrinology
(637)
Biotechnology For Biofuels
(613)
Diabetes Therapy
(604)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia

Nonlinear Control for Blood Glucose Regulation of Diabetic Patients: An LMI Approach

What does sodium‐glucose co‐transporter 1 inhibition add: Prospects for dual inhibition

Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?

Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity

Understanding the clinical implications of differences between glucose management indicator and glycated haemoglobin

Uric acid and the cardio‐renal effects of SGLT2 inhibitors

The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes

Changes in the use of glucose‐lowering drugs: A Danish nationwide study

One‐hour post‐load plasma glucose predicts progression to prediabetes in a multi‐ethnic cohort of obese youths

In vivo glucose sensing

Efficacy of 1‐hour postload plasma glucose as a suitable measurement in predicting type 2 diabetes and diabetes‐related complications: A post hoc analysis of the 30‐year follow‐up of the Da Qing IGT and Diabetes Study

Sodium‐glucose co‐transporter‐2 inhibitors as add‐on therapy to insulin for type 1 diabetes mellitus: Systematic review and meta‐analysis of randomized controlled trials

The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial

Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial

Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients

Comparative effects of proximal and distal small intestinal administration of metformin on plasma glucose and glucagon‐like peptide‐1, and gastric emptying after oral glucose, in type 2 diabetes

Effects of luseogliflozin, a sodium-glucose co-transporter 2 inhibitor, on 24-h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, crossover study

Sodium‐glucose co‐transporter‐2 inhibitor use and dietary carbohydrate intake in Japanese individuals with type 2 diabetes: A randomized, open‐label, 3‐arm parallel comparative, exploratory study

Sodium‐glucose co‐transporter‐2 inhibitors and diabetic ketoacidosis: An updated review of the literature

Bimagrumab improves body composition and insulin sensitivity in insulin‐resistant individuals

Decreased complexity of glucose time series index associated with adverse pregnancy outcomes in gestational diabetes mellitus

Beta‐cell sensitivity to glucose is impaired after gastric bypass surgery

Aktive Filter

Suchergebnisse filtern